Gay and Bisexual Men’s Strategies to Maintain Daily Adherence to Their HIV Pre-exposure Prophylaxis (PrEP) Medication: Results from a Qualitative Study

被引：0
作者：
Christian Grov
Anthony W. P. Flynn
Alexa B. D’Angelo
Javier Lopez-Rios
David W. Pantalone
Ian W. Holloway
Jeffrey T. Parsons
机构：
[1] CUNY Graduate School of Public Health and Health Policy,Department of Community Health and Social Sciences
[2] CUNY Institute for Implementation Science in Population Health (ISPH),Department of Counseling Psychology
[3] University of Wisconsin Madison,Department of Social Welfare
[4] University of Massachusetts Boston,Hunter College of CUNY, The Center for HIV/AIDS Educational Studies and Training (CHEST)
[5] University of California Los Angeles,undefined
[6] The Graduate Center of CUNY,undefined
来源：
Prevention Science | 2019年 / 20卷
关键词：
Pre-exposure prophylaxis (PrEP); Adherence; Gay and bisexual men; HIV; Qualitative data;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Since FDA approval in 2012, HIV pre-exposure prophylaxis (PrEP) has been adopted by key populations, including gay and bisexual men (GBM), to reduce their HIV transmission risk. Given that PrEP is optimally effective when taken as prescribed, it is critical to understand the adherence strategies GBM use. We conducted one-on-one, semi-structured interviews with GBM taking PrEP in 2015–2016 (n = 103). Using thematic analysis, we identified six adherence strategies, with most participants (84.3%) utilizing multiple strategies to maintain adequate adherence: (1) integrating PrEP into part of a daily routine, (2) using a pillbox, (3) cognitive strategies/visual cues, (4) setting recurring smartphone alarms or reminders, (5) keeping medication on oneself at all times, and (6) partner or peer support for reminders and/or pill sharing. Overall, participants reported high PrEP adherence (M = 1.6 missed doses in the prior 30 days), though nearly all described missing at least one dose unintentionally in the past. Participants credited their high levels of adherence in part to the strategies they adopted. Providers working with GBM prescribed PrEP, especially patients reporting difficulties with adherence, might consider recommending any or all of the six strategies described in this study.
引用
收藏
页码：168 / 177
页数：9
相关论文
共 180 条
  • [11] Mendys P(2014)Uptake of pre-exposure prophylaxis, sexual practices, and HIV incidence in men and transgender women who have sex with men: a cohort study The Lancet Infectious Diseases 14 820-138
  • [12] Brindis R(2016)Current concepts for PrEP adherence: in the PrEP revolution; from clinical trials to routine practice Current Opinion in HIV and AIDS 11 10-1009
  • [13] Burkholder R(2014)HIV providers’ perceived barriers and facilitators to implementing pre-exposure prophylaxis in care settings: a qualitative study AIDS and Behavior 18 1712-253
  • [14] Czajkowski SM(2015)Antiretrovirals for primary HIV prevention: the current status of pre- and post-exposure prophylaxis Current HIV/AIDS Reports 12 127-627
  • [15] Chaiyachati KH(2010)How are habits formed: Modelling habit formation in the real world European Journal of Social Psychology 40 998-2879
  • [16] Ogbuoji O(2013)Tailored text messaging intervention for HIV adherence: a proof-of-concept study Health Psychology 32 248-S35
  • [17] Price M(2014)Medication adherence among men who have sex with men at risk for HIV infection in the United States: implications for pre-exposure prophylaxis implementation AIDS Patient Care and STDs 28 622-455
  • [18] Suthar AB(2002)Interventions to enhance patient adherence to medication prescriptions: Scientific review Journal of the American Medical Association 288 2868-S382
  • [19] Negussie EK(2014)A systematic review of the frequency and correlates of partner abuse in HIV-infected women and men who partner with men Journal of the Association of Nurses in AIDS Care 25 S15-915
  • [20] Barnighausen T(2015)Accuracy of highly sexually active gay and bisexual men's predictions of their daily likelihood of anal sex and its relevance for intermittent event-driven HIV pre-exposure prophylaxis Journal of Acquired Immune Deficiency Syndromes 68 449-834
12345678910